{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:51:04Z","timestamp":1792608664965,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11910-022-01232-4","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T05:03:37Z","timestamp":1664773417000},"page":"689-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-5530","authenticated-orcid":false,"given":"Michael Tran","family":"Duong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3554-3481","authenticated-orcid":false,"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"6","key":"1232_CR1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327 (Important paper from a consensus panel that establishes recommendations for diagnosing LATE.).","journal-title":"Brain."},{"issue":"3","key":"1232_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jnen\/nlz126","volume":"79","author":"LM Besser","year":"2020","unstructured":"Besser LM, Teylan MA, Nelson PT. Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations. J Neuropathol Exp Neurol. 2020;79(3):305\u201313.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5796","key":"1232_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133 (One of the first studies to discover TDP-43 pathology in neurodegenerative diseases, including FTLD and ALS.).","journal-title":"Science."},{"issue":"3","key":"1232_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602\u201311 (One of the first studies to discover TDP-43 pathology in neurodegenerative diseases, including FTLD and ALS.).","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"1232_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21154","volume":"61","author":"C Amador-Ortiz","year":"2007","unstructured":"Amador-Ortiz C, Lin W-L, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease. Ann Neurol. 2007;61(5):435\u201345 (First study to find TDP-43 inclusions in hippocampal sclerosis and AD.).","journal-title":"Ann Neurol."},{"issue":"1","key":"1232_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","volume":"144","author":"PT Nelson","year":"2022","unstructured":"Nelson PT, Brayne C, Flanagan ME, et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022;144(1):27\u201344 (Updated study determining prevalence of LATE in older adults.).","journal-title":"Acta Neuropathol."},{"key":"1232_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"1232_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","volume":"16","author":"A Meneses","year":"2021","unstructured":"Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N. TDP-43 Pathology in Alzheimer\u2019s disease. Mol Neurodegen. 2021;16:84.","journal-title":"Mol Neurodegen"},{"key":"1232_CR9","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1038\/s41598-020-71305-2","volume":"10","author":"DX Thomas","year":"2020","unstructured":"Thomas DX, Bajaj S, McRae-McKee K, Hadjichrsanthou C, Anderson RM, Collinge J. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer\u2019s disease neuropathology. Sci Rep. 2020;10:14579.","journal-title":"Sci Rep"},{"issue":"7","key":"1232_CR10","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141(7):2181\u201393.","journal-title":"Brain"},{"key":"1232_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF00293396","volume":"88","author":"DW Dickson","year":"1994","unstructured":"Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or =80 years of age) humans. Acta Neuropathol. 1994;88:212\u201321 (First pathological study to define hippocampal sclerosis, a common neuroanatomical feature in LATE.).","journal-title":"Acta Neuropathol."},{"key":"1232_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.15585\/mmwr.mm6746a1","volume":"67","author":"P Mehta","year":"2018","unstructured":"Mehta P, Kaye W, Raymond J, et al. Prevalence of amyotrophic lateral sclerosis \u2014 United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:1285\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1232_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/09540261.2013.776523","volume":"25","author":"CU Onyike","year":"2013","unstructured":"Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry. 2013;25(2):130\u20137.","journal-title":"Int Rev Psychiatry"},{"issue":"9","key":"1232_CR14","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/acn3.51135","volume":"7","author":"OL Lopez","year":"2020","unstructured":"Lopez OL, Kofler J, Chang YF, et al. Hippocampal sclerosis, TDP-43, and the duration of the symptoms of dementia of AD patients. Ann Clin Transl Neurol. 2020;7(9):1546\u201356.","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"1232_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","volume":"16","author":"KA Josephs","year":"2017","unstructured":"Josephs KA, Dickson DW, Tosakulwong N, et al. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer\u2019s disease: a longitudinal retrospective study. Lancet Neurol. 2017;16(11):917\u201324.","journal-title":"Lancet Neurol"},{"issue":"14","key":"1232_CR16","doi-asserted-by":"publisher","first-page":"e1951","DOI":"10.1212\/WNL.0000000000010454","volume":"95","author":"A Kapasi","year":"2020","unstructured":"Kapasi A, Yu L, Boyle PA, Barnes LL, Bennett DA, Schneider JA. Limbic-predominant age-related TDP-43 encephalopathy (LATE), ADNC pathology, and cognitive decline in aging. Neurology. 2020;95(14):e1951\u201362 (Recent study on the influence of LATE and AD pathologies on cognitive decline rates.).","journal-title":"Neurology."},{"issue":"14","key":"1232_CR17","doi-asserted-by":"publisher","first-page":"e1422","DOI":"10.1212\/WNL.0000000000200001","volume":"98","author":"KM Gauthreaux","year":"2022","unstructured":"Gauthreaux KM, Teylan MA, Katsumata Y, et al. Limbic-predominant age-related TDP-43 encephalopathy: medical and pathologic factors associated with comorbid hippocampal sclerosis. Neurology. 2022;98(14):e1422\u201333 (Important study dissecting the differences in clinical and pathological factors affecting LATE with HS vs. LATE without HS.).","journal-title":"Neurology."},{"issue":"11","key":"1232_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","volume":"70","author":"RS Wilson","year":"2013","unstructured":"Wilson RS, Yu L, Trojanowski JQ, et al. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013;70(11):1418\u201324.","journal-title":"JAMA Neurol"},{"issue":"3","key":"1232_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Murray ME, Whitwell JL, et al. Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2014;127(3):441\u201350.","journal-title":"Acta Neuropathol"},{"key":"1232_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-018-0531-3","volume":"6","author":"S Nag","year":"2018","unstructured":"Nag S, Yu L, Boyle PA, Leurgans SE, Bennett DA, Schneider JA. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6:33.","journal-title":"Acta Neuropathol Commun"},{"key":"1232_CR21","doi-asserted-by":"crossref","unstructured":"Liu KY, Reeves S, McAleese KE, Attems J, Francis P, Thomas A, Howard R. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer\u2019s disease. Brain. 143(12):3842\u20133849. Important investigation on neurological and psychiatric symptoms in LATE and AD.","DOI":"10.1093\/brain\/awaa315"},{"issue":"3","key":"1232_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1212\/01.WNL.0000133008.89613.82","volume":"63","author":"DM Blass","year":"2004","unstructured":"Blass DM, Hatanpaa KJ, Rao V, Steinberg M, Troncoso JC, Rabins PV. Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology. 2004;63(3):492\u20137.","journal-title":"Neurology"},{"issue":"10","key":"1232_CR23","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","volume":"52","author":"M Jo","year":"2020","unstructured":"Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med. 2020;52(10):1652\u201362.","journal-title":"Exp Mol Med"},{"key":"1232_CR24","doi-asserted-by":"crossref","unstructured":"Cohen TJ, Lee VM-Y, Trojanowski TJ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med. 2011;17(11):659\u2013667.","DOI":"10.1016\/j.molmed.2011.06.004"},{"issue":"4","key":"1232_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1471-4159.2009.06383.x","volume":"111","author":"C Colombrita","year":"2009","unstructured":"Colombrita C, Zennaro E, Fallini C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111(4):1051\u201361.","journal-title":"J Neurochem"},{"issue":"5","key":"1232_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","volume":"71","author":"L McGurk","year":"2018","unstructured":"McGurk L, Gomes E, Guo L, et al. Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol Cell. 2018;71(5):703\u201317.","journal-title":"Mol Cell"},{"issue":"2","key":"1232_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","volume":"30","author":"SJ Barmada","year":"2010","unstructured":"Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci. 2010;30(2):639\u201349.","journal-title":"J Neurosci"},{"issue":"21","key":"1232_CR28","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1073\/pnas.1917038117","volume":"117","author":"JJ Herzog","year":"2020","unstructured":"Herzog JJ, Xu W, Deshpande M, et al. TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression. Proc Natl Acad Sci USA. 2020;117(21):11760\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuron.2017.05.037","volume":"95","author":"RC Paolicelli","year":"2017","unstructured":"Paolicelli RC, Jawaid A, Henstridge CM, et al. TDP-43 Depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron. 2017;95:293\u2013308.","journal-title":"Neuron"},{"issue":"11","key":"1232_CR30","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/brain\/aww224","volume":"139","author":"BD James","year":"2016","unstructured":"James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia. Brain. 2016;139(11):2983\u201393.","journal-title":"Brain"},{"issue":"7","key":"1232_CR31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/nan.12732","volume":"47","author":"S Porta","year":"2021","unstructured":"Porta S, Xu Y, Lehr T, et al. Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo. Neuropathol Appl Neurobiol. 2021;47(7):1033\u201349.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"1232_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00401-016-1666-6","volume":"133","author":"RH Tan","year":"2017","unstructured":"Tan RH, Ke YD, Ittner LM, Halliday GM. ALS\/FTLD: experimental models and reality. Acta Neuropathol. 2017;133(2):177\u201396.","journal-title":"Acta Neuropathol"},{"key":"1232_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2021","unstructured":"de Boer EMJ, Orie VK, Williams T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2021;92:86\u201395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"R2","key":"1232_CR34","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","volume":"26","author":"T Niccoli","year":"2017","unstructured":"Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS\/FTD. Hum Mol Genet. 2017;26(R2):R105\u201313.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1232_CR35","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/brain\/awaa219","volume":"143","author":"JL Robinson","year":"2020","unstructured":"Robinson JL, Porta S, Garrett FG, et al. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain. 2020;143(9):2844\u201357.","journal-title":"Brain"},{"issue":"4","key":"1232_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","volume":"15","author":"C Wider","year":"2009","unstructured":"Wider C, Dickson DW, Stoessl AJ, et al. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord. 2009;15(4):281\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"1232_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000289231","volume":"7","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Baker M, Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegenerative Dis. 2010;7:170\u20134 (One of the first inquiries into genetic risk for hippocampal sclerosis.).","journal-title":"Neurodegenerative Dis."},{"issue":"6","key":"1232_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","volume":"21","author":"IRA Mackenzie","year":"2008","unstructured":"Mackenzie IRA, Rademakers R. The role of TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol. 2008;21(6):693\u2013700.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"1232_CR39","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"1232_CR40","doi-asserted-by":"publisher","first-page":"10256","DOI":"10.1073\/pnas.1001412107","volume":"107","author":"DA Wolk","year":"2010","unstructured":"Wolk DA, Dickerson BC. Alzheimer\u2019s disease neuroimaging initiative. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2010;107(22):10256\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.647990","volume":"13","author":"MT Duong","year":"2021","unstructured":"Duong MT, Nasrallah IM, Wolk DA, Chang CCY, Chang T-Y. Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy. Front Aging Neurosci. 2021;13: 647990.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"1232_CR42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","volume":"17","author":"H-S Yang","year":"2018","unstructured":"Yang H-S, Yu L, Whie CC, et al. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol. 2018;17(9):773\u201381.","journal-title":"Lancet Neurol"},{"key":"1232_CR43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.neuron.2020.05.010","volume":"107","author":"H-S Yang","year":"2020","unstructured":"Yang H-S, White CC, Klein H-U, et al. Genetics of gene expression in the aging human brain reveal TDP-43 proteinopathy pathophysiology. Neuron. 2020;107:496\u2013508 (Important study that identified several risk loci of TDP-43 proteinopathies.).","journal-title":"Neuron."},{"issue":"6","key":"1232_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-014-1282-2","volume":"127","author":"PT Nelson","year":"2014","unstructured":"Nelson PT, Estus S, Abner EL, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 2014;127(6):825\u201343.","journal-title":"Acta Neuropathol"},{"key":"1232_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-021-01250-2","volume":"9","author":"AJ Dugan","year":"2021","unstructured":"Dugan AJ, Nelson PT, Katsumata Y, et al. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Comm. 2021;9:152.","journal-title":"Acta Neuropathol Comm"},{"issue":"4","key":"1232_CR46","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/hmg\/dds475","volume":"22","author":"OA Brady","year":"2013","unstructured":"Brady OA, Zheng Y, Murphy K, Huang M, Hu F. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Hum Mol Genet. 2013;22(4):685\u201395.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1232_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ajhg.2017.09.004","volume":"101","author":"MD Gallagher","year":"2017","unstructured":"Gallagher MD, Posavi M, Huang P, et al. A dementia-associated risk variant near TMEM106B alters chromatin architecture and gene expression. Am J Hum Genet. 2017;101(5):643\u201363.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1232_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin VM, Sleiman PMA, Martinez-Lage M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234\u20139 (First study to map the genetic architecture of TDP-43 disorders.).","journal-title":"Nat Genet."},{"issue":"Pt 3","key":"1232_CR49","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awr007","volume":"134","author":"J van der Zee","year":"2011","unstructured":"van der Zee J, Van Langenhove T, Kleinberger G, et al. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain. 2011;134(Pt 3):808\u201315 (First study to map the genetic architecture of TDP-43 disorders.).","journal-title":"Brain."},{"issue":"9","key":"1232_CR50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/WNL.0000000000001313","volume":"84","author":"L Yu","year":"2015","unstructured":"Yu L, De Jager PL, Yang J, Trojanowski JQ, Bennett DA, Schneider JA. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology. 2015;84(9):927\u201334.","journal-title":"Neurology"},{"key":"1232_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53:1276\u201382.","journal-title":"Nat Genet"},{"issue":"1","key":"1232_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00401-019-02066-0","volume":"139","author":"Z Li","year":"2020","unstructured":"Li Z, Farias FHG, Dube U, et al. The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. Acta Neuropathol. 2020;139(1):45\u201361.","journal-title":"Acta Neuropathol"},{"key":"1232_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2022.02.026","volume":"185","author":"A Chang","year":"2022","unstructured":"Chang A, Xiang X, Wang J, et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell. 2022;185:1\u201310.","journal-title":"Cell"},{"key":"1232_CR54","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang YX, Cao Q, Sawaya MR, et al. Amyloid fibrils in disease FTLD-TDP are composed of TMEM106B not TDP-43. Nature. 2022;605:304\u20139.","journal-title":"Nature"},{"key":"1232_CR55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser M, Arseni D, Bacioglu M, et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature. 2022;605:310\u20134.","journal-title":"Nature"},{"issue":"3","key":"1232_CR56","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awaa438","volume":"144","author":"JL Robinson","year":"2021","unstructured":"Robinson JL, Richardson H, Xie SX, et al. The development and convergence of copathologies in Alzheimer\u2019s disease. Brain. 2021;144(3):953\u201362.","journal-title":"Brain"},{"key":"1232_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40478-019-0743-1","volume":"7","author":"CS Latimer","year":"2019","unstructured":"Latimer CS, Burke BT, Liachko NF, et al. Resistance and resilience to Alzheimer\u2019s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort. Acta Neuropathol Commun. 2019;7:91.","journal-title":"Acta Neuropathol Commun"},{"key":"1232_CR58","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","volume":"11","author":"Y-H Shih","year":"2020","unstructured":"Shih Y-H, Tu L-H, Chang T-Y, et al. TDP-43 interacts with amyloid-\u03b2, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease. Nat Commun. 2020;11:5950.","journal-title":"Nat Commun"},{"key":"1232_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40478-018-0641-y","volume":"6","author":"Y Katsumata","year":"2018","unstructured":"Katsumata Y, Fardo DW, Kukull WA, Nelson PT. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer\u2019s disease and cerebrovascular disease pathologies. Acta Neuropathol Comm. 2018;6:142.","journal-title":"Acta Neuropathol Comm"},{"key":"1232_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-022-01319-6","volume":"10","author":"S Raghavan","year":"2022","unstructured":"Raghavan S, Przybelski SA, Reid RI, et al. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition. Acta Neuropathol Comm. 2022;10:16.","journal-title":"Acta Neuropathol Comm"},{"issue":"3","key":"1232_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12939","volume":"31","author":"S Agrawal","year":"2021","unstructured":"Agrawal S, Yu L, Kapasi A, et al. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol. 2021;31(3): e12939.","journal-title":"Brain Pathol"},{"issue":"1","key":"1232_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-021-02383-3","volume":"143","author":"MT Uemura","year":"2022","unstructured":"Uemura MT, Robinson JL, Cousins KAQ, et al. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Acta Neuropathol. 2022;143(1):15\u201331 (Recent investigation elucidating the histopathological differences between LATE+LBD and LATE+AD.).","journal-title":"Acta Neuropathol."},{"key":"1232_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40478-021-01260-0","volume":"9","author":"S Agrawal","year":"2021","unstructured":"Agrawal S, Yu L, Nag S, et al. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer\u2019s dementia in older persons. Acta Neuropathol Commun. 2021;9:156.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"1232_CR64","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3233\/JAD-181285","volume":"69","author":"E Bayram","year":"2019","unstructured":"Bayram E, Shan G, Cummings JL. Associations between comorbid TDP-43, Lewy body pathology, and neuropsychiatric symptoms in Alzheimer\u2019s disease. J Alzheimers Dis. 2019;69(4):953\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1232_CR65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007;114(3):221\u20139.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1232_CR66","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024554","volume":"7","author":"L Guo","year":"2017","unstructured":"Guo L, Shorter J. Biology and pathobiology of TDP-43 and emergent therapeutic strategies. Cold Spring Harb Perspect Med. 2017;7(9): a024554.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1232_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2019.01.022","volume":"77","author":"N Makkinejad","year":"2019","unstructured":"Makkinejad N, Schneider JA, Yu J, et al. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults. Neurobiol Aging. 2019;77:104\u201311.","journal-title":"Neurobiol Aging"},{"key":"1232_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s40478-021-01275-7","volume":"9","author":"S Ravikumar","year":"2021","unstructured":"Ravikumar S, Wisse LEM, Lim S, et al. Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology. Acta Neuropathol Comm. 2021;9:173 (Recent investigation comparing the effects of TDP-43 and tau pathology on MTL thickness on postmortem imaging.).","journal-title":"Acta Neuropathol Comm."},{"key":"1232_CR69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40478-021-01225-3","volume":"9","author":"LEM Wisse","year":"2021","unstructured":"Wisse LEM, Ravikumar S, Ittyerah R, et al. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions. Acta Neuropathol Comm. 2021;9:128 (Recent work to evaluate the contributions of TDP-43, amyloid, tau, and \u03b1-synuclein pathology on MTL thickness with ex vivo MRI.).","journal-title":"Acta Neuropathol Comm."},{"issue":"6","key":"1232_CR70","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/alz.12079","volume":"16","author":"R de Flores","year":"2020","unstructured":"de Flores R, Wisse LEM, Das SR, et al. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer\u2019s disease. Alzheimers Dement. 2020;16(6):843\u201352 (Important investigation on the effects of TDP-43 and tau pathology on MTL thickness. TDP-43 burden was associated with anterior MTL atrophy.).","journal-title":"Alzheimers Dement."},{"issue":"10","key":"1232_CR71","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1523\/JNEUROSCI.0949-21.2021","volume":"42","author":"R de Flores","year":"2022","unstructured":"de Flores R, Das SR, Xie L, et al. Medial temporal lobe networks in Alzheimer\u2019s disease: structural and molecular vulnerabilities. J Neurosci. 2022;42(10):2131\u201341.","journal-title":"J Neurosci"},{"key":"1232_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102954","volume":"34","author":"M Buciuc","year":"2022","unstructured":"Buciuc M, Martin PR, Tosakulwong N, et al. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration. Neuroimage Clin. 2022;34: 102954.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"1232_CR73","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/brain\/awy049","volume":"141","author":"H Botha","year":"2018","unstructured":"Botha H, Mantyh WG, Murray ME, et al. FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain. 2018;141(4):1201\u201317 (First study to show a distinct 18F-FDG PET pattern for pathologically defined LATE.).","journal-title":"Brain."},{"key":"1232_CR74","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1212\/WNL.0000000000009722","volume":"85","author":"M Buciuc","year":"2020","unstructured":"Buciuc M, Botha H, Murray ME, et al. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology. 2020;85:e23\u201334 (Important study that improves an 18F-FDG PET pattern for LATE and compares this biomarker to structural MRI.).","journal-title":"Neurology."},{"issue":"S1","key":"1232_CR75","first-page":"1038","volume":"61","author":"S Tanzey","year":"2020","unstructured":"Tanzey S, Brooks A, Shao X, Scott P. Extraction of enriched phosphorylated TDP43 from ALS tissue for evaluation of new TDP-43 radiotracers. J Nucl Med. 2020;61(S1):1038.","journal-title":"J Nucl Med"},{"issue":"7891","key":"1232_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","volume":"601","author":"D Arseni","year":"2022","unstructured":"Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, Ryskeldi-Falcon B. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 2022;601(7891):139\u201343.","journal-title":"Nature"},{"key":"1232_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41181-019-0070-7","volume":"4","author":"S Tiepolt","year":"2019","unstructured":"Tiepolt S, Patt M, Aghakhanyan G, et al. Current radiotracers to image neurodegenerative diseases. EJNMMI Radiopharm Chem. 2019;4:17.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"1232_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T G\u00f3mez-Isla","year":"1997","unstructured":"G\u00f3mez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann Neurol. 1997;41(1):17\u201324.","journal-title":"Ann Neurol"},{"key":"1232_CR79","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Isla T, Frosch MP. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes. Nat Rev Neurol 2022;18(6):323\u2013332","DOI":"10.1038\/s41582-022-00642-9"},{"key":"1232_CR80","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ana.26233","volume":"90","author":"SR Das","year":"2021","unstructured":"Das SR, Lyu X, Duong MT, et al. Tau-atrophy variability reveals phenotypic heterogeneity in Alzheimer\u2019s disease. Ann Neurol. 2021;90:751\u201362 (First imaging study to explicitly model the mismatch between tau pathology and neurodegeneration on MRI).","journal-title":"Ann Neurol."},{"issue":"1","key":"1232_CR81","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41467-022-28941-1","volume":"13","author":"MT Duong","year":"2022","unstructured":"Duong MT, Das SR, Lyu X, et al. Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer\u2019s disease. Nat Commun. 2022;13(1):1495 (First PET study to infer non-AD copathologies such as TDP-43 and \u03b1-synuclein imaging patterns based on hypometabolism relative to AD tau accumulation.).","journal-title":"Nat Commun."},{"key":"1232_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40478-015-0195-1","volume":"3","author":"J Goossens","year":"2015","unstructured":"Goossens J, Vanmechelen E, Trojanowski JQ, et al. TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies. Acta Neuropathol Comm. 2015;3:15.","journal-title":"Acta Neuropathol Comm"},{"key":"1232_CR83","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-008-0389-8","volume":"116","author":"P Foulds","year":"2008","unstructured":"Foulds P, McAuley E, Gibbons L, et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008;116:141\u20136 (One of the first papers to detect plasma TDP-43 protein in patients with FTLD and AD. The patients with AD and TDP-43 biomarkers may in fact have mixed LATE with AD.).","journal-title":"Acta Neuropathol."},{"issue":"11","key":"1232_CR84","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","volume":"65","author":"P Steinacker","year":"2008","unstructured":"Steinacker P, Hendrich C, Sperfeld AD, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008;65(11):1481\u20137 (One of the first studies to detect elevated TDP-43 protein in the CSF of patients with TDP-43 pathology.).","journal-title":"Arch Neurol."},{"key":"1232_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.663637","volume":"12","author":"Y Ren","year":"2021","unstructured":"Ren Y, Li S, Chen S, et al. TDP-43 and phosphorylated TDP-43 levels in paired plasma and CSF samples in amyotrophic lateral sclerosis. Front Neurol. 2021;12: 663637.","journal-title":"Front Neurol"},{"issue":"1","key":"1232_CR86","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/acn3.51256","volume":"8","author":"L Beyers","year":"2021","unstructured":"Beyers L, G\u00fcnther R, Koch JC, et al. TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2021;8(1):271\u20137.","journal-title":"Ann Clin Transl Neurol"},{"key":"1232_CR87","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12883-018-1091-7","volume":"18","author":"V Majumder","year":"2018","unstructured":"Majumder V, Gregory JM, Barria MA, Green A, Pal S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 2018;18:90.","journal-title":"BMC Neurol"},{"issue":"1","key":"1232_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","volume":"117","author":"T Kasai","year":"2009","unstructured":"Kasai T, Tokuda T, Ishigami N, et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009;117(1):55\u201362.","journal-title":"Acta Neuropathol"},{"key":"1232_CR89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fnagi.2020.00166","volume":"12","author":"N Zhang","year":"2020","unstructured":"Zhang N, Gu D, Meng M, Gordon ML. TDP-43 is elevated in plasma neuronal-derived exosomes of patients with Alzheimer\u2019s disease. Front Aging Neurosci. 2020;12:166.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1232_CR90","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/JAD-201263","volume":"79","author":"L Sun","year":"2021","unstructured":"Sun L, Li W, Yue L, Xiao S. Blood TDP-43 combined with demographics information predicts dementia occurrence in community non-dementia elderly. J Alzheimers Dis. 2021;79(1):301\u20139.","journal-title":"J Alzheimers Dis"},{"key":"1232_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-022-00534-y","volume":"17","author":"AC Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez AC, Irwin DJ, Alcolea D, et al. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Mol Neurodegen. 2022;17:29 (Essential study identifying CSF markers of TDP-43 pathology in FTLD-TDP compared to FTLD-Tau and AD.).","journal-title":"Mol Neurodegen."},{"key":"1232_CR92","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2019.01.048","volume":"102","author":"JR Mann","year":"2019","unstructured":"Mann JR, Gleixner AM, Mauna JC, et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102:321\u201338.","journal-title":"Neuron"},{"key":"1232_CR93","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1212\/WNL.0000000000012419","volume":"97","author":"E Benarroch","year":"2021","unstructured":"Benarroch E. What is the role of stathmin-2 in axonal biology and degeneration? Neurology. 2021;97:330\u20133.","journal-title":"Neurology"},{"key":"1232_CR94","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim JR, Williams LA, Limone F, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22:167\u201379.","journal-title":"Nat Neurosci"},{"key":"1232_CR95","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed Z, L\u00f3pez-Erauskin J, Baughn MW, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22:180\u201390.","journal-title":"Nat Neurosci"},{"issue":"11","key":"1232_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139741","volume":"130","author":"M Prudencio","year":"2020","unstructured":"Prudencio M, Humphrey J, Pickles S, et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J Clin Invest. 2020;130(11): e139741.","journal-title":"J Clin Invest"},{"issue":"7","key":"1232_CR97","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/NEN.0000000000000204","volume":"74","author":"ET Ighodaro","year":"2015","unstructured":"Ighodaro ET, Jicha GA, Schmitt FA, et al. Hippocampal sclerosis of aging can be segmental: two cases and review of the literature. J Neuropathol Exp Neurol. 2015;74(7):642\u201352.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-022-01232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-022-01232-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-022-01232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T11:37:14Z","timestamp":1667648234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-022-01232-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1007\/s11910-022-01232-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"21 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"David A. Wolk reports grants from Merck, Biogen, Eli Lilly\/Avid and additional fees from GE Healthcare, Functional Neuromodulation and Neuronix, all outside of this work. Michael Tran Duong has no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}